Skip to content
Recall Observatory FDA recall evidence

Drug product

Clindamycin Phosphate Topical Solution USP, 1%, packaged in a) 30 mL applicator bottles (NDC 0472-0987-91) and b) 60 mL applicator bottles (NDC 0472-0987-92), Rx Only, Manufactured by: G&W Laboratories, Inc., 111 Coolidge Street, South Plainfield, NJ 07080; Distributed by: Actavis Mid Atlantic LLC, 1877 Kawai Road, Lincolnton, NC 28092.

D-0519-2017

February 28, 2017

Class III

Product summary

Firm
G & W Laboratories, Inc.
Event
Event 76641
Status
Terminated
Classification
Class III
Quantity
39,816 bottles
Official record key
drug-enforcement:D-0519-2017

Official wording

Reason: CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.

Code information: Lot #'s: a) 032100042, 032100043, 032100044, 032100045, Exp 06/17; b) 032100038, 032100039, 032100040, 032100041, Exp 05/17; 032100046, 032100047, 032100048, 032100049, Exp 06/17.

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations